InMode Ltd. Ordinary Shares (INMD) Stock: Buy, Sell, or Hold?
INMD - InMode Ltd. Ordinary Shares
$14.03
-0.11 (-0.78%)
▼
5d:
-1.75%
30d:
-2.91%
90d:
-7.02%
WAIT
LOW Confidence
Analysis Updated: Oct 21, 2026 12:00 AM ET
Earnings: Nov 11, 2026
19d
Smart Money Accumulation
Options open interest is building while the stock consolidates - a pattern consistent with institutional accumulation. View Scanner →
Signal fired Oct 15, 2026 at $14.32 · last confirmed Oct 21, 2026
Strength: 6.3/10
Get Alerted When INMD Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: INMD shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: INMD shows conflicting indicators. Wait for confirmation before entering.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$16.77
Based on 5.0% avg growth
INTRINSIC VALUE TODAY
$10.41
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 9.6x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: INMD is currently trading at $14.03, which is considered oversold relative to its 30-day fair value range of $14.04 to $14.50. The stock's valuation (Forward PE: 10.2) is in line with its historical norms (9.6). At these levels, the market is pricing in 2.2% annual earnings growth.
Technical Outlook: Technically, INMD is showing sideways momentum. The price is currently testing key support at $13.86. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock scores a mixed 50/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. In the options market, Implied Volatility is low (2th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $16.17 (+15.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, INMD is showing sideways momentum. The price is currently testing key support at $13.86. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock scores a mixed 50/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. In the options market, Implied Volatility is low (2th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $16.17 (+15.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$14.04 -
$14.50
Company Quality Score
50/100
(HOLD)
Options IV Signal
2th percentile
(LOW)
Volume Confirmation
HIGH
Confidence Score
84.2%
Protect Your Profits
Holding INMD? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Options cheap (IV 2th percentile)
- NEUTRAL: Mixed technical signals (50/100)
- BULLISH: High volume confirmation
- BULLISH: Trading below Wall St target ($16.17)
- BULLISH: Expecting earnings turnaround to 2.2% growth with None% revenue growth
- WARNING: Composite score 50/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$14.04 -
$14.50
Current vs Trading Range
OVERSOLD
Expected Move (7 Days)
±$0.89
(6.3%)
Support & Resistance Levels
Support Level
$13.86
Resistance Level
$14.50
Current Trend
Sideways
Technical data as of
Oct 21, 2026
Fundamental Context
Forward P/E (Next Year Est.)
10.23
Wall Street Target
$16.17
(+15.2%)
Earnings Growth (YoY)
-31.0%
Profit Margin
20.7%
Valuation Premium vs History
+2.2% premium
PE vs Historical
10.2 vs 9.6
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+2.2%
(market-implied from PE analysis)
1-Year Target
$14.34
(+2%)
2-Year Target
$14.65
(+4%)
3-Year Target
$14.98
(+7%)
3-Yr Target (if PE normalizes)
(PE: 10→10)
PE COMPRESSION
$14.06
(+0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 19.9, Growth: 5.9%)
$32.33
(+130%)
Base:
(SPY PE: 10.2, Growth: 5.9%)
$16.65
(+19%)
Bear:
(PE: 8.7, Growth: 5.9%)
$14.15
(+1%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (12x PE), but valuation improves significantly next year (10x PE) as earnings recover.
Trailing PE: 11.59 | Current EPS (TTM): $1.22
Bull Case
$17.49
(+25%)
Analyst growth 12.5%, PE expands to 12.8
Base Case
$15.90
(+13%)
Market implied 12.5%, PE stable at 11.6
Bear Case
$9.62
(-32%)
Severe decline -20.0%, PE contracts to 9.9
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: October 22, 2026 6:36 AM ET
Data refreshes hourly during market hours. Next update: 7:36 AM
Data refreshes hourly during market hours. Next update: 7:36 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is INMD showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
DXCM
DexCom Inc |
STRONG BUY
29 analysts |
$96 | 50 HOLD |
|
EW
Edwards Lifesciences Corp |
STRONG BUY
29 analysts |
$102 | 59 HOLD |
|
ABT
Abbott Laboratories |
STRONG BUY
28 analysts |
$121 | 53 HOLD |
|
SYK
Stryker Corporation |
STRONG BUY
29 analysts |
$363 | 37 SELL |
|
CATX
Perspective Therapeutics… |
STRONG BUY
14 analysts |
$12 | 60 HOLD |
Advanced INMD Option Strategies
Professional options setups generated by AI based on today's INMD price and gamma walls.
